The Union Health Ministry of India has banned the use of ‘antibody detecting rapid diagnostic tests’ for routine malaria diagnosis due to concerns over the practicality of the approach.

Various media sources reported that the ministry has issued an order to cease the manufacture for sale, sale and distribution of kits for these tests ‘with immediate effect’.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

“The prohibition is based on the observation that serological testing is not practical for the routine diagnosis of acute malaria because of the time required to develop the antibody.”

The antibody detection for malaria is carried out through an indirect fluorescent antibody test in patients infected with Plasmodium, which is the known causative organism of the disease.

Issued in public interest, the prohibition is based on the observation that serological testing is not practical for routine diagnosis of the acute form of the disease because of the time required to develop the antibody.

The testing is attributed to the persistence of antibodies even after clearance of an active infection and evidence suggests that serology only measures past exposure but does not identify existing infection.

While the antibody detecting rapid diagnostic tests are preferred for their low cost and free availability, they are reported to have led to a high false positive rate in endemic areas.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

This is thought to be due to the fact that patients with fever, which is caused by factors other than malaria, test negative with antigen detection but positive while using these rapid diagnostic tests.

The government said that the ban will not impact the diagnosis of malaria sufferers as the most common tests used in diagnosis are antigen detecting rapid diagnostic tests and blood smear examination. Therefore, there would not be any problems faced for malaria diagnosis by banning the antibody detecting rapid diagnostic tests.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact